{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:13:41Z","timestamp":1790813621925,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.lanepe.2024.100901","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:44:46Z","timestamp":1712443486000},"page":"100901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study"],"prefix":"10.1016","volume":"40","author":[{"given":"Jean-Beno\u00eet","family":"Arlet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Herquelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lamarsalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-371X","authenticated-orcid":false,"given":"Fanny","family":"Raguideau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2024.100901_bib1","series-title":"Bilan d\u2019activit\u00e9 2021","article-title":"Association Fran\u00e7aise pour le d\u00e9pistage et la pr\u00e9vention des handicaps de l\u2019enfant","year":"2021"},{"issue":"8","key":"10.1016\/j.lanepe.2024.100901_bib2","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the global burden of disease study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.lanepe.2024.100901_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253986","article-title":"Epidemiology and disease burden of sickle cell disease in France: a descriptive study based on a French nationwide claim database","volume":"16","author":"Leleu","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lanepe.2024.100901_bib4","first-page":"2476","article-title":"Severity and burden of sickle cell disease in France: a nationwide realworld study","volume":"108","author":"Brousse","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.lanepe.2024.100901_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease","volume":"325","author":"Platt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2024.100901_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2024.100901_bib7","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l'Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev \u00c9pid\u00e9miolo Sant\u00e9 Publique"},{"key":"10.1016\/j.lanepe.2024.100901_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.lanepe.2024.100901_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100901_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100901_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.revmed.2023.05.006","article-title":"La dr\u00e9panocytose: une maladie qui s\u2019impose aux internistes Fran\u00e7ais au 21e si\u00e8cle","volume":"44","author":"Arlet","year":"2023","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.lanepe.2024.100901_bib12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00277-020-04233-w","article-title":"Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries","volume":"99","author":"Desai","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lanepe.2024.100901_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.36469\/9667","article-title":"Evaluation of vaso-occlusive crises in United States sickle cell disease patients: a retrospective claims-based study","volume":"6","author":"Shah","year":"2019","journal-title":"J\u00a0Health Econ Outcomes Res"},{"key":"10.1016\/j.lanepe.2024.100901_bib14","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.lanepe.2024.100901_bib15","first-page":"2274","article-title":"Impact of renal function on hydroxyurea exposure in sickle-cell disease patients","volume":"87","author":"Pressiat","year":"2021","journal-title":"Br\u00a0J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.lanepe.2024.100901_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","article-title":"Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive \u2018switching\u2019 agent. The multicenter study of hydroxyurea in sickle cell anemia","volume":"75","author":"Charache","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lanepe.2024.100901_bib17","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell anemia in sub-saharan africa","volume":"382","author":"John","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2024.100901_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13023-021-02096-6","article-title":"A\u00a0systematic literature review of frequency of vaso-occlusive crises in sickle cell disease","volume":"16","author":"Zaidi","year":"2021","journal-title":"Orphanet J\u00a0Rare Dis"},{"key":"10.1016\/j.lanepe.2024.100901_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.revmed.2022.04.019","article-title":"Syndrome thoracique aigu chez les patients dr\u00e9panocytaires adultes","volume":"43","author":"Cheminet","year":"2022","journal-title":"Rev M\u00e9decine Interne"},{"key":"10.1016\/j.lanepe.2024.100901_bib20","first-page":"1193","article-title":"Thromboprophylaxis reduced venous thromboembolism in sickle cell patients with central venous access devices: a retrospective cohort study","volume":"11","author":"Fort\u00e9","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.lanepe.2024.100901_bib21","first-page":"717","article-title":"Validation\u00a0of discharge diagnosis of sickle cell disease vaso-occlusive episodes in the French hospital electronic database","volume":"13","author":"Walter","year":"2021","journal-title":"Clin\u00a0Epidemiol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622400067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622400067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:49:37Z","timestamp":1714988977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622400067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":21,"alternative-id":["S266677622400067X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100901","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100901"}}